These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 567274)

  • 1. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro.
    Graham DG; Tiffany SM; Bell WR; Gutknecht WF
    Mol Pharmacol; 1978 Jul; 14(4):644-53. PubMed ID: 567274
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture.
    Michel PP; Hefti F
    J Neurosci Res; 1990 Aug; 26(4):428-35. PubMed ID: 1977925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. R(-)-deprenyl potentiates dopamine-induced cytotoxicity toward catecholaminergic neuroblastoma SH-SY5Y cells.
    Lai CT; Yu PH
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):186-91. PubMed ID: 9007048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levodopa and dopamine analogs as DNA polymerase inhibitors and antitumor agents in human melanoma.
    Wick MM
    Cancer Res; 1980 May; 40(5):1414-8. PubMed ID: 6768447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catecholamine toxicity: a proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease.
    Graham DG
    Neurotoxicology; 1984; 5(1):83-95. PubMed ID: 6538951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-Hydroxydopamine toxicity to dopamine neurons in culture: potentiation by the addition of superoxide dismutase and N-acetylcysteine.
    Mytilineou C; Danias P
    Biochem Pharmacol; 1989 Jun; 38(11):1872-5. PubMed ID: 2735944
    [No Abstract]   [Full Text] [Related]  

  • 7. An in vitro bacterial model of cytotoxicity to living cells caused by dopamine and 6-hydroxydopamine oxidation at physiological pH.
    Giunta S; Galeazzi L; Groppa G
    Free Radic Biol Med; 1991; 10(5):297-303. PubMed ID: 1906828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of GADD45 and GADD153 in neuroblastoma cells by dopamine-induced toxicity.
    Stokes AH; Freeman WM; Mitchell SG; Burnette TA; Hellmann GM; Vrana KE
    Neurotoxicology; 2002 Dec; 23(6):675-84. PubMed ID: 12520757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the mechanisms of 6-hydroxydopamine cytotoxicity.
    Jonsson G
    Med Biol; 1976 Dec; 54(6):406-20. PubMed ID: 1034180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity of dopamine to mouse neuroblastoma x rat glioma hybrid (NG108) cells in vitro.
    Wang RG; Zhu XZ
    Zhongguo Yao Li Xue Bao; 1995 Jul; 16(4):294-6. PubMed ID: 7668093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones.
    Graham DG
    Mol Pharmacol; 1978 Jul; 14(4):633-43. PubMed ID: 98706
    [No Abstract]   [Full Text] [Related]  

  • 12. Model experiments on the molecular mechanism of action of 6-hydroxydopamine.
    Saner A; Thoenen H
    Mol Pharmacol; 1971 Mar; 7(2):147-54. PubMed ID: 5125851
    [No Abstract]   [Full Text] [Related]  

  • 13. Selective toxicity of 6-hydroxydopamine and ascorbate for human neuroblastoma in vitro: a model for clearing marrow prior to autologous transplant.
    Reynolds CP; Reynolds DA; Frenkel EP; Smith RG
    Cancer Res; 1982 Apr; 42(4):1331-6. PubMed ID: 7037175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of metabolism and oxidation-reduction cycling in the cytotoxicity of antitumor quinoneimines and quinonediimines.
    Powis G; Hodnett EM; Santone KS; See KL; Melder DC
    Cancer Res; 1987 May; 47(9):2363-70. PubMed ID: 3032421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When quinones meet amino acids: chemical, physical and biological consequences.
    Bittner S
    Amino Acids; 2006 May; 30(3):205-24. PubMed ID: 16601927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A potential role for cyclized quinones derived from dopamine, DOPA, and 3,4-dihydroxyphenylacetic acid in proteasomal inhibition.
    Zafar KS; Siegel D; Ross D
    Mol Pharmacol; 2006 Sep; 70(3):1079-86. PubMed ID: 16790533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic aspects of the interaction of ascorbic acid with alloxan and 6-hydroxydopamine.
    Heikkila RE; Cohen G
    Ann N Y Acad Sci; 1975 Sep; 258():221-30. PubMed ID: 1060403
    [No Abstract]   [Full Text] [Related]  

  • 18. Iron-mediated generation of the neurotoxin 6-hydroxydopamine quinone by reaction of fatty acid hydroperoxides with dopamine: a possible contributory mechanism for neuronal degeneration in Parkinson's disease.
    Pezzella A; d'Ischia M; Napolitano A; Misuraca G; Prota G
    J Med Chem; 1997 Jul; 40(14):2211-6. PubMed ID: 9216840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine toxicity involves mitochondrial complex I inhibition: implications to dopamine-related neuropsychiatric disorders.
    Ben-Shachar D; Zuk R; Gazawi H; Ljubuncic P
    Biochem Pharmacol; 2004 May; 67(10):1965-74. PubMed ID: 15130772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines.
    Beall HD; Murphy AM; Siegel D; Hargreaves RH; Butler J; Ross D
    Mol Pharmacol; 1995 Sep; 48(3):499-504. PubMed ID: 7565631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.